Apr 14, 2021 17:16 Source: BSE
Divis Laboratories - Certificate Pursuant To Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half Year Ended March 31, 2021
Please find the enclosed certificate dated April 14, 2021 obtained from V. Bhaskara Rao & Associates, Practicing Company Secretaries for the half year ended March 31, 2021, pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Apr 07, 2021 15:57 Source: BSE
Divis Laboratories - Statement Of Investor Complaints For The Quarter Ended March 2021
| No.of Investor complaints pending at the beginning of the quarter || No.of Investor complaints received during the quarter|| No.of Investor complaints disposed of during the quarter || No.of Investor complaints unresolved at the end of the quarter |
| Name of the Signatory || :- ||M Satish Choudhury|
|Designation || :- ||Company Secretary and Compliance Officer|
Apr 06, 2021 15:02 Source: BSE
Divis Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate for the quarter ended March 31, 2021 received from M/s. KFin Technologies Private Limited, Registrar & Share Transfer Agent of the Company.
Apr 06, 2021 14:31 Source: BSE
Divis Laboratories - Compliance Certificate For Half Year Ended March 31, 2021
Pursuant to Regulation7(3) of the SEBI (LODR) Regulations, 2015, we enclose herewith Compliance Certificate from the Company and the Registrar and Share Transfer Agent for half year ended March 31, 2021.
Apr 06, 2021 12:19 Source: BSE
Divis Laboratories - Shareholding for the Period Ended March 31, 2021
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
Mar 31, 2021 8:40 Source: BSE
Divis Laboratories - Closure of Trading Window
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading (the Code), we hereby inform that the Trading Window for dealing in securities of the Company will remain closed for all Designated Persons and their Immediate Relatives, as well as Insiders covered under the Code, from 01 April, 2021 till 48 hours after the declaration of Audited Financial Results of the Company for the fourth quarter and year ending on 31 March, 2021. The date of Board Meeting for declaration of the financial results of the Company for the fourth quarter and year ending on 31 March, 2021 will be intimated in due course.
Mar 24, 2021 16:45 Source: BSE
Divis Laboratories - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Request for issue of Duplicate Share Certificate